These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 27453251

  • 21. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.
    Evans JD, Girerd B, Montani D, Wang XJ, Galiè N, Austin ED, Elliott G, Asano K, Grünig E, Yan Y, Jing ZC, Manes A, Palazzini M, Wheeler LA, Nakayama I, Satoh T, Eichstaedt C, Hinderhofer K, Wolf M, Rosenzweig EB, Chung WK, Soubrier F, Simonneau G, Sitbon O, Gräf S, Kaptoge S, Di Angelantonio E, Humbert M, Morrell NW.
    Lancet Respir Med; 2016 Feb; 4(2):129-37. PubMed ID: 26795434
    [Abstract] [Full Text] [Related]

  • 22. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension.
    Antigny F, Hautefort A, Meloche J, Belacel-Ouari M, Manoury B, Rucker-Martin C, Péchoux C, Potus F, Nadeau V, Tremblay E, Ruffenach G, Bourgeois A, Dorfmüller P, Breuils-Bonnet S, Fadel E, Ranchoux B, Jourdon P, Girerd B, Montani D, Provencher S, Bonnet S, Simonneau G, Humbert M, Perros F.
    Circulation; 2016 Apr 05; 133(14):1371-85. PubMed ID: 26912814
    [Abstract] [Full Text] [Related]

  • 23. Clinical and genetic characteristics of pulmonary arterial hypertension in Lebanon.
    Abou Hassan OK, Haidar W, Nemer G, Skouri H, Haddad F, BouAkl I.
    BMC Med Genet; 2018 May 30; 19(1):89. PubMed ID: 29843651
    [Abstract] [Full Text] [Related]

  • 24. The genetic basis of pulmonary arterial hypertension.
    Ma L, Chung WK.
    Hum Genet; 2014 May 30; 133(5):471-9. PubMed ID: 24442418
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF, Cao A, Lai YJ, Wang L, Chen PI, Alcazar MAA, de Jesus Perez VA, Hopper RK, Rhodes CJ, Bill MA, Sakai LY, Rabinovitch M.
    Arterioscler Thromb Vasc Biol; 2017 Aug 30; 37(8):1559-1569. PubMed ID: 28619995
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Phenotype and outcome of pulmonary arterial hypertension patients carrying a TBX4 mutation.
    Thoré P, Girerd B, Jaïs X, Savale L, Ghigna MR, Eyries M, Levy M, Ovaert C, Servettaz A, Guillaumot A, Dauphin C, Chabanne C, Boiffard E, Cottin V, Perros F, Simonneau G, Sitbon O, Soubrier F, Bonnet D, Remy-Jardin M, Chaouat A, Humbert M, Montani D.
    Eur Respir J; 2020 May 30; 55(5):. PubMed ID: 32079640
    [Abstract] [Full Text] [Related]

  • 29. Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.
    Prewitt AR, Ghose S, Frump AL, Datta A, Austin ED, Kenworthy AK, de Caestecker MP.
    J Biol Chem; 2015 Jan 09; 290(2):960-71. PubMed ID: 25411245
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Computed tomographic findings in TBX4 mutation: a common cause of severe pulmonary artery hypertension in children.
    Neves da Silva HV, Weinman JP, Englund EK, Deterding RR, Ivy DD, Browne LP.
    Pediatr Radiol; 2024 Feb 09; 54(2):199-207. PubMed ID: 38191808
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Genetics of pulmonary arterial hypertension.
    Elliott CG.
    Clin Chest Med; 2013 Dec 09; 34(4):651-63. PubMed ID: 24267296
    [Abstract] [Full Text] [Related]

  • 39. StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2.
    Deliu N, Das R, May A, Newman J, Steele J, Duckworth M, Jones RJ, Wilkins MR, Toshner MR, Villar SS.
    Trials; 2024 Oct 15; 25(1):680. PubMed ID: 39407331
    [Abstract] [Full Text] [Related]

  • 40. Contributions of BMPR2 Mutations and Extrinsic Factors to Cellular Phenotypes of Pulmonary Arterial Hypertension Revealed by Induced Pluripotent Stem Cell Modeling.
    Kiskin FN, Chang CH, Huang CJZ, Kwieder B, Cheung C, Dunmore BJ, Serrano F, Sinha S, Morrell NW, Rana AA.
    Am J Respir Crit Care Med; 2018 Jul 15; 198(2):271-275. PubMed ID: 29547009
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.